{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:42:16Z","timestamp":1784691736944,"version":"3.55.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold>Schizophrenia is a lifelong condition associated with several comorbid conditions such as physical illnesses like obesity, as well as co-occurring psychiatric symptoms such as depression. Research regarding susceptibility to some of these comorbidities has primary focused on genetic risks or neurotransmitters and very little work has been done to understand environmental factors such as diet. In particular, understanding the role of dietary glutamic acid consumption on co-morbidities in patients with schizophrenia is important, as evidence suggests that glutamic acid consumption may directly influence glutamatergic neurotransmission; a key neurotransmitter related to schizophrenia, its associated co-morbidities, and depression. Therefore, the aim of this study was to examine the potential relationship between dietary glutamic acid and depressive symptomatology in patients with schizophrenia, stratified by obesity status, due to its relationship with inflammation, antipsychotic use, and depressive symptoms.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Subjects included in this analysis, were part of a parent cross-sectional study in which included three dietary recalls analyzed using protocols outlined as part of the National Health and Nutrition Examination Surveys (NHANES) standardized criteria. Additionally, body mass index (BMI), and Beck Depression Inventory were obtained at this visit. Subjects with a BMI \u2265 30 kg\/m<jats:sup>2<\/jats:sup>were included in the obesity group, and the relationship between glutamic acid consumption and BDI scores was analyzed after controlling for age, race, sex, antidepressant and antipsychotic use, and animal and vegetable protein intake which provide natural forms of dietary glutamic acid.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>A total of 168 participants were included in this study, of which 42.5% were female and 52.9% were White. The mean BMI for the group as a whole was 33.5 \u00b1 8.7 (kg\/m<jats:sup>2<\/jats:sup>) and the mean BDI was 14.5 \u00b1 10.2 (range 2\u201350). No differences were found between obesity groups, other than a greater hyperlipidemia, hypertension, and lower waist to hip ratio. Overall, no relationship was found between dietary glutamic acid and BDI scores, However, for non-obese participants, diets higher levels of glutamic acid were associated with greater depression symptomatology (<jats:italic>p<\/jats:italic>= 0.021).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>These preliminary results indicate a possible correlation between dietary glutamic acid a depressive symptoms in non-obese patients with schizophrenia, although further research is needed to specifically examine this relationship.<\/jats:p>","DOI":"10.3389\/fpsyt.2020.620097","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T09:44:17Z","timestamp":1611222257000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia"],"prefix":"10.3389","volume":"11","author":[{"given":"Pooja","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Zarina","family":"Kraal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Prawdzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison E.","family":"Ringold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Ellingrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/schbul\/sbw097","article-title":"Depression and schizophrenia: cause, consequence, or trans-diagnostic issue?","volume":"43","author":"Upthegrove","year":"2017","journal-title":"Schizophr Bull"},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","article-title":"The intriguing relationship between coronary heart disease and mental disorders","volume":"20","author":"De Hert","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1038\/s41467-019-13544-0","article-title":"Genetic correlations of psychiatric traits with body composition and glycemic traits are sex- and age-dependent","volume":"10","author":"Hubel","year":"2019","journal-title":"Nat Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.neubiorev.2019.09.025","article-title":"Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders","volume":"107","author":"Morris","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2174\/138161210790361416","article-title":"Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex","volume":"16","author":"L\u00f3pez-Gil","year":"2010","journal-title":"Curr Pharm Des"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.schres.2015.02.006","article-title":"Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders","volume":"164","author":"Grove","year":"2015","journal-title":"Schizophr Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/biom10060947","article-title":"Brain NMDA receptors in schizophrenia and depression","volume":"10","author":"Adell","year":"2020","journal-title":"Biomolecules."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.3390\/ijms21186758","article-title":"The epigenetic overlap between obesity and mood disorders: a systematic review","volume":"21","author":"Gharipour","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","article-title":"Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders","volume":"78","author":"de Melo","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fnins.2020.00863","article-title":"Environment and gene association with obesity and their impact on neurodegenerative and neurodevelopmental diseases","volume":"14","author":"Flores-Dorantes","year":"2020","journal-title":"Front Neurosci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8076397","DOI":"10.1155\/2018\/8076397","article-title":"The influence of metabolic syndrome and sex on the DNA methylome in schizophrenia","volume":"2018","author":"Burghardt","year":"2018","journal-title":"Int J Genomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/bdi.12422","article-title":"Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance","volume":"18","author":"Burghardt","year":"2016","journal-title":"Bipolar Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15046","DOI":"10.1038\/npjschz.2015.46","article-title":"The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects","volume":"1","author":"Ellingrod","year":"2015","journal-title":"NPJ Schizophr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5498\/wjp.v10.i8.187","article-title":"Dietary modification in the treatment of schizophrenia spectrum disorders: a systematic review","volume":"10","author":"Aucoin","year":"2020","journal-title":"World J Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpsm.2019.10.003.","article-title":"Eating and nutritional habits in patients with schizophrenia","author":"Zurron Madera","year":"2019","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"B18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bdi.12160","article-title":"Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population","volume":"16","author":"Bly","year":"2014","journal-title":"Bipolar Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/oby.2008.274","article-title":"Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP study","volume":"16","author":"He","year":"2008","journal-title":"Obesity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/15376516.2018.1528649","article-title":"Patho-physiological and toxicological aspects of monosodium glutamate","volume":"29","author":"Chakraborty","year":"2019","journal-title":"Toxicol Mech Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2014.04.032","article-title":"Monosodium glutamate, a food additive, induces depressive-like and anxiogenic-like behaviors in young rats","volume":"107","author":"Quines","year":"2014","journal-title":"Life Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbr.2015.12.038","article-title":"Diphenyl diselenide elicits antidepressant-like activity in rats exposed to monosodium glutamate: a contribution of serotonin uptake and Na(+), K(+)-ATPase activity","volume":"301","author":"Quines","year":"2016","journal-title":"Behav Brain Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.lfs.2013.07.009","article-title":"Neonatal treatment with monosodium glutamate lastingly facilitates spreading depression in the rat cortex","volume":"93","author":"Lima","year":"2013","journal-title":"Life Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.3390\/ijms150711473","article-title":"Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice","volume":"15","author":"Hernandez-Bautista","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4939-8994-2_3","article-title":"Monosodium glutamate (MSG)-induced animal model of type 2 diabetes","volume":"1916","author":"Bahadoran","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S0007114510000760","article-title":"Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: findings from the Jiangsu Nutrition Study of Chinese adults","volume":"104","author":"Shi","year":"2010","journal-title":"Br J Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/ejp.874","article-title":"Increased pain and muscle glutamate concentration after single ingestion of monosodium glutamate by myofascial temporomandibular disorders patients","volume":"20","author":"Shimada","year":"2016","journal-title":"Eur J Pain"},{"key":"B28","first-page":"10","article-title":"The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms","volume":"30","author":"Holton","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1468-2982.2009.01881.x","article-title":"Effect of systemic monosodium glutamate (MSG) on headache and pericranial muscle sensitivity","volume":"30","author":"Baad-Hansen","year":"2010","journal-title":"Cephalalgia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/JCP.0b013e3182485888","article-title":"Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics","volume":"32","author":"Ellingrod","year":"2012","journal-title":"J Clin Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1176\/ps.45.1.18","article-title":"DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders","volume":"45","author":"First","year":"1994","journal-title":"Hosp Community Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psychres.2011.07.009","article-title":"Self-assessment of psychological stress in schizophrenia: preliminary evidence of reliability and validity","volume":"195","author":"Tso","year":"2012","journal-title":"Psychiatry Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol Psychiatry."},{"key":"B34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/0019-5545.111475","article-title":"Current perspectives on chlorpromazine equivalents: comparing apples and oranges!","volume":"55","author":"Danivas","year":"2013","journal-title":"Indian J Psychiatry"},{"key":"B35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0002-8223(21)07997-9","article-title":"Sources of data for developing and maintaining a nutrient database","volume":"88","author":"Schakel","year":"1988","journal-title":"J Am Diet Assoc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000494778","article-title":"Review of Glutamate Intake from Both Food Additive and Non-Additive Sources in the European Union","volume":"73","author":"Tennant","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1058S","DOI":"10.1093\/jn\/130.4.1058S","article-title":"Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study","volume":"130","author":"Geha","year":"2000","journal-title":"J Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/oxfordjournals.aje.a010184","article-title":"Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet","volume":"151","author":"Nelson","year":"2000","journal-title":"Am J Epidemiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/jn\/113.9.1851","article-title":"Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame","volume":"113","author":"Stegink","year":"1983","journal-title":"J Nutr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1586\/14737175.2016.1157471","article-title":"Influence of pro-algesic foods on chronic pain conditions","volume":"16","author":"Cairns","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000496294","article-title":"Could dietary glutamate play a role in psychiatric distress?","volume":"79","author":"Kraal","year":"2020","journal-title":"Neuropsychobiology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00726-015-2073-3","article-title":"Homeostatic effect of p-chloro-diphenyl diselenide on glucose metabolism and mitochondrial function alterations induced by monosodium glutamate administration to rats","volume":"48","author":"Quines","year":"2016","journal-title":"Amino Acids"},{"key":"B43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/1028415X.2017.1398301","article-title":"Monosodium glutamate and treadmill exercise: anxiety-like behavior and spreading depression features in young adult rats","volume":"22","author":"Vitor-de-Lima","year":"2019","journal-title":"Nutr Neurosci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-020-01845-x","article-title":"Role of glucocorticoid receptor phosphorylation-mediated synaptic plasticity in anxiogenic and depressive behaviors induced by monosodium glutamate","volume":"394","author":"Zhu","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bj.2020.01.001","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/21623945.2020.1831825","article-title":"Glutamine metabolism in adipocytes: a bona fide epigenetic modulator of inflammation","volume":"9","author":"Lecoutre","year":"2020","journal-title":"Adipocyte"},{"key":"B47","doi-asserted-by":"publisher","first-page":"16364","DOI":"10.1038\/s41598-020-73347-y","article-title":"Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance","volume":"10","author":"Kochumon","year":"2020","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0091-6749(97)80008-5","article-title":"The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study","volume":"99","author":"Yang","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/oxfordjournals.aje.a114084","article-title":"Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats","volume":"122","author":"Block","year":"1985","journal-title":"Am J Epidemiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000177635","article-title":"Limitations of the various methods for collecting dietary intake data","volume":"35","author":"Bingham","year":"1991","journal-title":"Ann Nutr Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"E114","DOI":"10.1188\/11.CJON.E114-E121","article-title":"Diet assessment methods: a guide for oncology nurses","volume":"15","author":"Ralph","year":"2011","journal-title":"Clin J Oncol Nurs"},{"key":"B52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4162\/nrp.2010.4.2.142","article-title":"Relative validities of 3-day food records and the food frequency questionnaire","volume":"4","author":"Yang","year":"2010","journal-title":"Nutr Res Pract"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.620097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T14:42:23Z","timestamp":1670856143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.620097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":52,"alternative-id":["10.3389\/fpsyt.2020.620097"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.620097","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"article-number":"620097"}}